NMDA-ANTAGONIST-PRODRUGS

European patent · EP3564234 · In force

Register entry

Publication number
EP3564234
Application number
EP19166031
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 30, 2014
Published
Nov 6, 2019
Granted
Sep 29, 2021
Protection ends at the latest
Oct 29, 2034
Next annual fee due
Oct 31, 2026
IPC classes
C07D 401/14 (2006.01)
C07D 401/12 (2006.01)
C07D 213/40 (2006.01)
A61K 31/4402 (2006.01)
A61K 31/4439 (2006.01)
A61P 25/24 (2006.01)
Priority
US 201361899903 P 05.11.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Jan 26, 2024

    Change

    Published in Swissreg on 26.01.2024

  4. Jan 9, 2023

    Address changed

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 09.01.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Aug 10, 2022

    Change

    Published in Swissreg on 10.08.2022

  7. Nov 11, 2021

    Agent entered

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich

    Published in Swissreg on 11.11.2021

  8. Sep 29, 2021

    Granted

    Published in Swissreg on 29.09.2021

Parties

Holder

AstraZeneca AB

151 85 Södertälje, SE

Agent

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventor

WEIGELT, Dirk

Macclesfield Cheshire SK10 4TG, GB

QUIRK, Michael

Waltham, Massachusetts 02451, US

HÖGDIN, Katharina

Macclesfield Cheshire SK10 4TG, GB

BERNSTEIN, Peter

Waltham, Massachusetts 02451, US

KERS, Annika

Macclesfield Cheshire SK10 4TG, GB

NORDVALL, Gunnar

Macclesfield Cheshire SK10 4TG, GB

BALESTRA, Michael

Waltham, Massachusetts 02451, US

MALMBORG, Per Jonas

Macclesfield Cheshire SK10 4TG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.